newsfilter
← Latest News
GlobeNewswire·

Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders

HOUSTON, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), developer of Deep Intracranial Frequency Stimulation (DIFS™) technology for non-invasive deep